Dendritic cell-based immunotherapy (DCVAC/OvCa) combined with second-line chemotherapy in platinum-sensitive ovarian cancer (SOV02): A randomized, open-label, phase 2 trial
Cibula, David, Rob, Lukas, Mallmann, Peter, Knapp, Pawel, Klat, Jaroslav, Chovanec, Josef, Minar, Lubos, Melichar, Bohuslav, Hein, Alexander, Kieszko, Dariusz, Pluta, Marek, Spacek, Jiri, Bartos, Pavel, Wimberger, Pauline, Madry, Radoslaw, Markowska, Janina, Streb, Joanna, Valha, Petr, Hassan, Hariz Iskandar Bin, Pecen, Ladislav, Galluzzi, Lorenzo, Fucikova, Jitka, Hrnciarova, Tereza, Hraska, Marek, Bartunkova, Jirina, Spisek, Radek
Published in Gynecologic oncology (01.09.2021)
Published in Gynecologic oncology (01.09.2021)
Get full text
Journal Article
525 Preliminary safety, PK/PD and efficacy results from a first-in-human phase I/IIa clinical trial of BNT411, a systemic Toll-like receptor 7 agonist in patients with solid tumors
Symeonides, Stefan, Mahalingam, Devalingam, Chae, Young Kwang, Calvo, Emiliano, Miguel, Maria, Arkenau, Hendrik-Tobias, Garralda, Elena, Galvao, Vladimir, Mita, Alain, Hassan, Hariz, Baumhauer, Annette, Völker, Timo, Kühnle, Marie-Cristine, Rösemann, Roman, Strobl, Stefan, Tuereci, Oezlem, Sahin, Ugur
Published in Journal for immunotherapy of cancer (01.11.2021)
Published in Journal for immunotherapy of cancer (01.11.2021)
Get full text
Journal Article
Dendritic cell vaccine (DCVAC) with chemotherapy (ct) in patients (pts) with epithelial ovarian carcinoma (EOC) after primary debulking surgery (PDS): Interim analysis of a phase 2, open-label, randomized, multicenter trial
Rob, Lukas, Mallmann, Peter, Knapp, Pawel, Melichar, Bohuslav, Klat, Jaroslav, Minar, Lubos, Novotny, Zdenek, Bartunkova, Jirina, Spisek, Radek, Pecen, Ladislav, Hassan, Hariz Iskandar Bin, Cibula, David
Published in Journal of clinical oncology (20.05.2018)
Published in Journal of clinical oncology (20.05.2018)
Get full text
Journal Article
Dendritic cell vaccine (DCVAC) with chemotherapy (ct) in patients (pts) with recurrent epithelial ovarian carcinoma (EOC) after complete response (CR) to 1st-line platinum (Pt)-based ct: Primary analysis of a phase 2, open-label, randomized, multicenter trial
Cibula, David, Mallmann, Peter, Knapp, Pawel, Melichar, Bohuslav, Klat, Jaroslav, Minar, Lubos, Novotny, Zdenek, Wimberger, Pauline, Hein, Alexander, Spisek, Radek, Bartunkova, Jirina, Pecen, Ladislav, Hassan, Hariz Iskandar Bin, Rob, Lukas
Published in Journal of clinical oncology (20.05.2018)
Published in Journal of clinical oncology (20.05.2018)
Get full text
Journal Article
TLR7 AGONIST AND COMBINATIONS FOR CANCER TREATMENT
RÖSEMANN, Roman, HASSAN, Hariz Iskandar Bin, SAHIN, Ugur, STROBL, Stefan
Year of Publication 18.09.2024
Get full text
Year of Publication 18.09.2024
Patent
TLR7 AGONIST AND COMBINATIONS FOR CANCER TREATMENT
RÖSEMANN, Roman, HASSAN, Hariz Iskandar Bin, SAHIN, Ugur, STROBL, Stefan
Year of Publication 11.04.2024
Get full text
Year of Publication 11.04.2024
Patent
TLR7 AGONIST AND COMBINATIONS FOR CANCER TREATMENT
RÖSEMANN, Roman, HASSAN, Hariz Iskandar Bin, SAHIN, Ugur, STROBL, Stefan
Year of Publication 19.05.2023
Get full text
Year of Publication 19.05.2023
Patent
TLR7 AGONIST AND COMBINATIONS FOR CANCER TREATMENT
ROSEMANN, ROMAN, STROBL, STEFAN, SAHIN, UGUR, HASSAN, HARIZ ISKANDAR BIN
Year of Publication 19.05.2023
Get full text
Year of Publication 19.05.2023
Patent